GlassScriptPhysician profile
Joseph D Whitlark
NPI 1760461180
$109,568.68
in general payments reported to CMS, 2019-2025
20 companies · $2,043 in 2025
The $2,043 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,508 · 2020: $1,570 · 2021: $371 · 2022: $75K · 2023: $15K · 2024: $8,752 · 2025: $2,043.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $4,435 · Education: $3,000 · Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,200.00 |
| Travel and Lodging | $4,435.38 |
| Education | $3,000.00 |
| Food and Beverage | $1,152.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon Endo-Surgery INC. | $62,115.00 | 2022 | |
| Galvanize Therapeutics, INC | $18,726.78 | 2022-2025 | Aliya System |
| Ethicon INC. | $13,156.89 | 2019-2025 | Monarch Platform |
| Intuitive Surgical, INC. | $4,892.23 | 2019-2023 | Da Vinci Surgical System |
| Biocomposites INC | $3,650.00 | 2019 | |
| Curetis USA INC. | $1,600.00 | 2019 | |
| Medical Device Business Services, INC. | $1,560.09 | 2025 | Monarch |
| Noah Medical Corporation | $1,224.59 | 2023 | |
| Boston Scientific Corporation | $1,018.84 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $994.16 | 2020-2021 | |
| Body Vision Medical INC. | $165.61 | 2024 | Lungvision |
| Novocure INC. | $129.73 | 2022 | |
| Stryker Corporation | $101.26 | 2025 | 1788 |
| On Target Laboratories, INC | $90.00 | 2025 | Cytalux |
| Bard Access Systems, INC. | $46.58 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $24.29 | 2019 | |
| Medela LLC | $23.85 | 2019 | |
| Baxter Healthcare | $19.05 | 2021 | |
| Covidien LP | $15.38 | 2020 | |
| Lilly USA, LLC | $14.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Whitlark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.